[1]
R. Mustarichie, D. Ramdhani, and W. Indriyati, “ANALYSIS OF FORBIDDEN PHARMACEUTICAL COMPOUINDS IN ANTIRHEUMATIC JAMU”, Asian J Pharm Clin Res, vol. 10, no. 4, pp. 98–101, Apr. 2017.